The unlimited potential of AI & RNA
We started ShapeTX with the vision of repairing the genetic causes of disease.
We’re realizing that vision by combining AI and RNA technology to make programmable RNA medicine available for everyone.
Board of Directors
Ed Mathers
General Partner, New Enterprise Associates
Min Cui, PhD
Founder & Managing Partner, Decheng Capital
Gayathri Rajan
Chief Product Officer, DriveWealth; Former VP/GM, Google
Kelly Sims
Board Advisor, Watershed and OpenAI; Former Head of Communications, Stripe
Josef von Rickenbach, PhD
Founder & Former CEO, Parexel
Leadership
Francois Vigneault, PhD
Co-Founder
Chief Executive Officer
John Suliman
Co-Founder
Chief Financial Officer
Prashant Mali, PhD
Co-Founder
Professor, Department of Bioengineering, University of California San Diego
David Huss, PhD
Chief Scientific Officer
Lisa Taylor Ash, JD
General Counsel
Gary Fortin, PhD
Chief Operating Officer
Patrick Bigot
Chief Business Officer
Adrian Briggs, PhD
Chief Technology Officer
Ron Hause, PhD
SVP, Head of AI
Jamie Siemering
VP, People Operations
Drew Dietz, MD
VP, Clinical Research & Development
Ken Prentice
VP, Process & Product Development
Scientific Advisory Board
George Church, PhD
Professor, Genetics, Harvard Medical School
Don Cleveland, PhD
Professor, Cellular Molecular Medicine, UCSD
James Collins, PhD
Professor, Bioengineering, MIT
You. And a universe of possibilities.
If you are ready to think completely differently about science, join us.